Interference with BRG1 and FOXM1 or the chemical inhibition of FOXM1 can abrogate the cardiac-stress-induced shift from ACE2 to ACE and protect the heart from myocardial hypertrophy. The gene discussed is ACE2; the disease is cardiac hypertrophy.